Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
BMC Biotechnology|August 27, 2025
A novel feeder cell based on 4-1BBL and membrane-bound IL-21/IL-15 induce highly expansion and anti-tumor effect of natural killer cellsSha Gong, Nan Mei, Jun Wang, et al.
Cancer Discovery|May 13, 2022
Sequential Single-Cell Transcriptional and Protein Marker Profiling Reveals TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin LymphomaZachary Jackson, Changjin Hong, Robert Schauner, et al.
Cancer Research|June 4, 2008
Identification of 6-benzylthioinosine as a myeloid leukemia differentiation-inducing compoundDavid N Wald, Hanna M Vermaat, Shaolei Zang, et al.
Cancer Letters|May 7, 2010
p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCGVijay S Thakur, A R M Ruhul Amin, Rajib K Paul, et al.
Frontiers in Oncology|March 27, 2020
Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid LeukemiaMasumi Ueda, Tammy Stefan, Lindsay Stetson, et al.
Scientific Reports|October 19, 2019
Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cellsEvelyn O Ojo, Ashish Arunkumar Sharma, Ruifu Liu, et al.
Human Reproduction (Oxford, England)|April 2, 2002
Down's syndrome screening with nuchal translucency at 12(+0)-14(+0) weeks and maternal serum markers at 14(+1)-17(+0) weeks: a prospective studyP Rozenberg, L Malagrida, H Cuckle, et al.
Gynecologie, Obstetrique & Fertilite|March 14, 2007
[Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population]P Rozenberg, L Bussières, S Chevret, et al.
Blood Advances|November 3, 2018
Aberrant GSK3β nuclear localization promotes AML growth and drug resistanceJames J Ignatz-Hoover, Victoria Wang, Nathan M Mackowski, et al.
Mbio|February 5, 2026
Reduction of the HIV-1 reservoir in T cells from people with HIV-1 on suppressive antiretroviral therapy using expanded natural killer cellsMary Ann Checkley, Benjamin G Luttge, Cheryl M Cameron, et al.
Pageof 16